FDx Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,023
| Closed | -$254K | – | 807 |
|
|
2019
Q1 | $254K | Sell |
5,023
-4,954
| -50% | -$251K | 0.01% | 655 |
|
|
2018
Q4 | $591K | Buy |
9,977
+184
| +2% | +$10.9K | 0.05% | 271 |
|
|
2018
Q3 | $645K | Sell |
9,793
-1,130
| -10% | -$74.4K | 0.02% | 451 |
|
|
2018
Q2 | $552K | Sell |
10,923
-13,863
| -56% | -$701K | 0.02% | 511 |
|
|
2018
Q1 | $1.31M | Buy |
24,786
+11,245
| +83% | +$592K | 0.04% | 423 |
|
|
2017
Q4 | $629K | Buy |
+13,541
| New | +$629K | 0.02% | 709 |
|